BRETT MEADOR: Open Payments
NPI 1225493562 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 59 payments from 13 companies in 2025. Trend: 2023 $372 · 2024 $544 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $462 |
| GENZYME CORPORATION | 3 | $148 |
| Celltrion USA Inc. | 8 | $147 |
| Novo Nordisk Inc | 4 | $79 |
| Janssen Scientific Affairs, LLC | 1 | $70 |
| Ardelyx, Inc. | 2 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Madrigal Pharmaceuticals | 2 | $63 |
| Janssen Biotech, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $32 |
Products named: RINVOQ, DUPIXENT, VEGZELMA, TREMFYA, Wegovy, LINZESS, IBSRELA, XIFAXAN.
Industry payments across PA — which companies pay providers there.
